VYNE Therapeutics Cash from Investing (TTM) Insights

VYNE Therapeutics Inc (VYNE)

2.57 +0.25 (+10.78%) USD | NASDAQ | Apr 24, 16:00

2.55 -0.02 (-0.78%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	-57.35M
September 30, 2023	5.001M
June 30, 2023	4.915M
March 31, 2023	4.915M
December 31, 2022	15.67M
September 30, 2022	15.67M
June 30, 2022	15.75M
March 31, 2022	16.78M
December 31, 2021	1.027M
September 30, 2021	3.029M
June 30, 2021	3.029M
March 31, 2021	23.13M
December 31, 2020	89.11M

Date	Value
September 30, 2020	100.18M
June 30, 2020	85.57M
March 31, 2020	79.86M
December 31, 2019	41.37M
September 30, 2019	24.23M
June 30, 2019	47.13M
March 31, 2019	39.49M
December 31, 2018	-33.88M
September 30, 2018	-23.53M
June 30, 2018	-68.13M
March 31, 2018	-68.54M
December 31, 2017	-15.09M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-57.35M

Minimum

Dec 2023

100.18M

Maximum

Sep 2020

27.32M

Average

15.75M

Median

Jun 2022

Cash from Investing (TTM) Benchmarks